How to Document Substance Use Disorder Treatment Sessions

Documenting substance use disorder (SUD) treatment is harder than documenting most other clinical presentations. You are managing a population with elevated medical complexity, frequent legal entanglement, strict federal confidentiality rules that go beyond standard privacy requirements, and treatment models that do not map cleanly onto the SOAP or DAP formats you learned in graduate school.

This guide covers the documentation requirements that are specific to SUD treatment: initial screening tools, treatment plan requirements, motivational interviewing (MI) session notes, relapse prevention planning, prescriber coordination, court-mandated treatment records, the confidentiality protections under 42 CFR Part 2, and how to write progress notes that actually capture what matters clinically.

Initial Screening Documentation

Most SUD treatment episodes begin with a structured screening phase. The documentation from this phase is often what payers audit first, so precision matters.

Screening Tools to Include in the Record

Three tools appear regularly in SUD screening, and your documentation should capture both the administration and the clinical interpretation:

AUDIT (Alcohol Use Disorders Identification Test): The AUDIT is a 10-item self-report questionnaire that scores alcohol consumption, drinking behavior, and alcohol-related problems. A score of 8 or higher typically indicates hazardous or harmful drinking. Document the total score, the date administered, who administered it, and your clinical interpretation in the context of the client's presentation.

CAGE: A four-question screening tool (Have you ever felt you should Cut down? Annoyed by criticism? Guilty about drinking? Eye-opener first thing in the morning?). Two or more affirmative responses indicate significant alcohol problems. Document each item endorsed, the total score, and your assessment of its reliability given the client's presentation.

DAST-10 (Drug Abuse Screening Test): A 10-item tool for non-alcohol substance use. Scores of 3 or higher indicate a moderate to severe drug use problem. Document the same elements as AUDIT: score, date, administrator, and clinical interpretation.

For each tool, document whether the client completed it independently or with assistance, and whether you have reason to believe the results may underrepresent actual use (many clients minimize during initial screening). A simple note such as "Client completed AUDIT independently; reported score of 6; clinician notes inconsistency between score and client's description of daily drinking in the intake interview, suggesting actual use may be higher" gives reviewers and future treaters important context.

Documenting the Biopsychosocial Intake

The SUD intake goes beyond what a standard psychosocial assessment covers. In addition to the usual domains, document:

• Substances used (specify each substance, not just "polysubstance use")
• Route of administration for each substance
• Quantity, frequency, and duration of use for each substance
• Age of first use for each substance
• Longest period of abstinence and what supported it
• Withdrawal history: Has the client had withdrawal symptoms before? Seizures? Delirium tremens? This has direct medical management implications.
• Previous treatment episodes (where, when, modality, duration, reason for discharge)
• Current medications, including any medication-assisted treatment (MAT) such as buprenorphine, methadone, or naltrexone

Example: "Mr. Okafor is a 41-year-old man presenting for outpatient SUD treatment with a primary diagnosis of Alcohol Use Disorder, severe (F10.20). He reports drinking 8-12 beers daily for the past three years, escalating from weekend use beginning at age 22. He denies use of any other substances. He reports a prior detox admission in 2021, 5 days, completed without complication; he maintains 14 months of sobriety afterward before relapsing following a divorce. He reports no history of seizures or DTs. AUDIT score: 24. CAGE: 3/4 items endorsed."

Treatment Plan Requirements for SUD

SUD treatment plans are reviewed closely by insurers, licensing boards, and courts. They need to be more specific than the typical outpatient mental health treatment plan.

A compliant SUD treatment plan generally includes:

• Problem statement: Identify the specific substance(s), DSM-5 severity level (mild, moderate, severe), and functional impairment
• Long-term goal: Typically stated as sustained recovery or a specified reduction target for harm reduction models
• Short-term objectives: Measurable, time-bound, and specific. "Client will attend 3 AA meetings per week by end of month 1" is sufficient. "Client will improve coping skills" is not.
• Interventions: Specify the modality (MI, cognitive-behavioral therapy for SUD, contingency management, 12-step facilitation), frequency of sessions, and rationale for treatment selection
• MAT status: Document whether MAT is in place, who is prescribing, and the coordination plan
• Ancillary services: Employment support, housing, case management, parenting services, peer support
• Discharge criteria: What does successful completion look like? Be specific.

Many outpatient programs are required by their state to update treatment plans every 90 days. Document the review date, what changed, why it changed, and the client's participation in the revision.

Documenting Motivational Interviewing Sessions

Motivational interviewing is the evidence-based framework most commonly used in SUD treatment, and its documentation requires a different approach than a standard CBT session note.

MI is not a set of techniques you apply to a client — it is a relational approach that elicits the client's own motivation for change. Your progress notes should reflect this. Generic notes like "explored ambivalence regarding substance use" do not give a reviewer any sense of what actually happened or why it was clinically appropriate.

What to Capture in an MI Progress Note

Change talk: Note specific statements the client made that reflect desire, ability, reason, need, or commitment to change. Quote the client when possible.

Sustain talk: Note arguments the client made in favor of continued use. This is not a failure — it is diagnostic. A client who articulates both sides of their ambivalence is engaging authentically with the process.

OARS techniques used: Did you use open-ended questions, affirmations, reflections, or summaries in a way that was particularly effective or that the client responded to strongly? Brief notation of technique is useful for continuity.

Stage of change: Note your clinical assessment of where the client is on the transtheoretical model (precontemplation, contemplation, preparation, action, maintenance). This should be stated explicitly, because it drives the pacing of treatment.

Example MI progress note:

"Session focused on exploring client's ambivalence regarding reducing alcohol use. Client initially presented significant sustain talk, stating 'I don't think I have a problem, I just drink to wind down after work like everyone else.' When asked what his wife would say if she were in the room, client paused and noted 'she'd probably say I'm not present anymore.' Client then articulated several reasons to change (change talk): concerns about his health, acknowledging that he has missed his son's soccer games three times in the past month, and that he 'doesn't like who he's becoming.' Clinician used reflections to amplify change talk and explored client's own vision of his life without alcohol. Client rated his importance for change as 7/10 and his confidence as 4/10. Collaboratively identified confidence gap as primary focus for next session. Stage of change: contemplation, with movement toward preparation noted."

This note takes about the same time to write as a generic note, but it documents the specific clinical activity that occurred and its rationale.

Relapse Prevention Planning Notes

Relapse prevention planning is a structured clinical activity, and the documentation should reflect that it happened deliberately, not as an afterthought.

When you conduct a relapse prevention session, document:

• The specific triggers identified by the client (internal: boredom, loneliness, stress; external: specific people, places, events)
• High-risk situations the client anticipates in the near term (an upcoming family event where alcohol will be served, a work stress period)
• Coping strategies identified for each category of trigger
• Early warning signs of relapse the client recognizes in themselves (changes in sleep, isolation, minimizing their use in self-talk)
• Support contacts: Who the client will call when craving is high? Does that person know they are a support contact?
• Emergency protocol: What happens if the client uses? Who to call, whether to seek a higher level of care

Document the client's participation level. A client who actively generates their own trigger list and coping strategies is more engaged than one who nods while you fill in the form. This distinction matters clinically and can inform treatment plan updates.

Example: "Relapse prevention planning conducted with Mr. Okafor. Client identified three primary triggers: (1) stress from unresolved conflict with ex-spouse, (2) passing the bar where he used to drink on his commute home, and (3) social anxiety at family gatherings. Client developed specific coping strategies for each: call sponsor before engaging in the co-parenting conversation, take alternate route home, and arrive at gatherings with a non-alcoholic drink in hand to reduce social pressure. Client identified isolation as his primary early warning sign. Named three people he will contact in order if craving is high: sponsor J., his brother, and his therapist's after-hours line. Client participated actively in planning and stated he found it useful."

Coordination with Prescribers and Referral Sources

SUD treatment almost always involves coordination across providers. This coordination needs to be documented.

When you coordinate with a prescribing physician or psychiatrist (particularly around MAT), document:

• The date of communication and with whom
• What information was shared (and what releases were in place)
• Any changes to the client's MAT protocol that resulted
• Any concerns communicated about the client's status

When you receive a referral from another provider (primary care, emergency department, court), document the source, the date you received information, and what was contained in the referral. This matters for continuity and for legal accountability.

Sample coordination note: "Telephoned Dr. Martinez, prescribing physician, on 3/5/26 to report that client has missed two consecutive buprenorphine check-ins and has not responded to our outreach calls. Dr. Martinez requested that we continue outreach and document any contact attempts. Dr. Martinez will hold the prescription until client appears. ROI on file; expires 12/31/26."

Document all outreach attempts: date, time, method, and result ("left voicemail, no response").

Court-Mandated Treatment Documentation

Court-ordered SUD treatment creates additional documentation obligations. The court needs to know whether the client is attending, whether they are compliant with treatment requirements, and in some cases, whether they are progressing.

Separate your clinical notes from your court reporting documentation. Your progress notes reflect your clinical observations. Your compliance reports or status letters to the court should be a separate document that contains only what you are authorized to share under the client's release and what the court has requested.

Document the terms of the court order in the record: what treatment is required, how often, what constitutes non-compliance, and what the consequences of non-compliance are (probation violation, return to court, etc.). This protects you if a question arises later about what you were obligated to report.

What to document in compliance reports:

• Dates client attended
• Whether the client is in compliance with the program requirements
• Any significant clinical developments that the court needs to know under the terms of the release
• What you are NOT authorized to share (clinical content of sessions, the client's disclosures)

When in doubt about what you are authorized to report, document the question and your consultation with a supervisor or legal counsel. Courts sometimes pressure providers to share more than they are permitted to under 42 CFR Part 2 — and your documentation of how you navigated that pressure protects you.

42 CFR Part 2: The SUD-Specific Privacy Rules

This is where many clinicians stumble, and where documentation errors carry serious consequences.

42 CFR Part 2 is a federal regulation specifically governing records of patients in SUD treatment programs that receive any federal assistance. It is more restrictive than standard privacy regulations in several important ways:

1. Consent is required for nearly all disclosures. Unlike standard records, SUD treatment records covered under 42 CFR Part 2 cannot be disclosed without a specific written consent — even to other treating providers — unless the disclosure falls within a narrow set of exceptions.

2. The exceptions are narrow. Exceptions include: medical emergencies, communications within the treating program, audit and evaluation, and court orders that meet specific requirements. General "treatment purposes" is not a sufficient basis for disclosure.

3. Re-disclosure is prohibited. When you disclose SUD records with consent, you must include a written statement that the recipient is prohibited from re-disclosing the information.

What this means for documentation:

• Document every consent to release SUD records: date signed, what was authorized, who is the recipient, what information is covered, and the expiration date
• Note explicitly in the chart when a release of information expires
• Document when you declined to release information and why
• Do not document disclosures as routine if they required consent

Practical note: If your practice also provides non-SUD mental health services to the same client, the SUD-related records carry heightened protections even if they are in the same chart. Some programs maintain physically or electronically separate records for SUD treatment to reduce confusion. If your program does this, document how the separation is maintained.

Writing Progress Notes That Capture What Matters

SUD progress notes often default to generic language because the clinical content of each session can feel repetitive. "Client discussed recovery. Denied cravings. Encouraged continued sobriety." This kind of note provides minimal clinical or legal protection.

Strong SUD progress notes capture treatment engagement and behavioral markers, not just attendance and mood.

Behavioral Markers to Document

• Days of sobriety since last session (client self-report; note if verifiable, e.g., via Breathalyzer or UA)
• Attendance at support groups, with specifics ("attended 4 AA meetings this week, sponsored a newcomer")
• Employment and functioning (showing up to work, managing finances)
• Relationship functioning (repair of relationships damaged by use, conflict management)
• Housing stability
• Any use episode since the last session, including the client's account of triggers and the aftermath
• Follow-through on between-session commitments from the last note

Language That Works

Compare these two versions of the same session:

Generic: "Client reports sobriety since last session. Discussed continued recovery goals. Mood: good. Plan: continue current treatment."

Specific: "Client reports 14 days of sobriety, the longest period since treatment began. He attended four AA meetings, connected with a sponsor for the first time, and re-enrolled in his GED program. He disclosed a high craving episode on Wednesday triggered by a call from his ex-wife; he used the coping strategy from his relapse prevention plan (called his brother, took a walk) and did not use. Clinician reinforced this as a significant recovery achievement. Session focused on consolidating this success and preparing a response plan for the anticipated child custody hearing next month, which client identifies as a high-risk period. Stage of change: action, stable."

The second note takes only a few more minutes to write. It demonstrates clinical reasoning, captures specific behavioral evidence of recovery progress, and would hold up to a utilization review or legal scrutiny.

NotuDocs lets you build session note templates tailored to SUD documentation, so the structure is always in place and you are filling in what the client actually brought to the session. When you have separate templates for MI sessions, relapse prevention sessions, and standard progress notes, the difference in documentation quality becomes consistent rather than dependent on how much energy you have at the end of the day.

SUD Documentation Checklist

Use this before signing any SUD treatment record:

Initial Screening

• Screening tools administered, scored, and clinically interpreted (AUDIT, CAGE, DAST as appropriate)
• All substances documented by name, route, quantity, and duration
• Withdrawal history documented, including seizures or DTs
• MAT status documented, with prescriber identified

Treatment Plan

• Problem statement includes DSM-5 diagnosis with severity
• Goals are specific and measurable
• Interventions name the modality and rationale
• Discharge criteria stated explicitly
• Client signature on treatment plan documented

Progress Notes

• Days of sobriety recorded (note source)
• Treatment engagement documented (group attendance, sponsor contact, etc.)
• Any use episode since last session noted with triggers and aftermath
• Stage of change assessed
• MI sessions: change talk and sustain talk both documented
• Relapse prevention sessions: specific triggers, strategies, and support contacts

Coordination and Legal

• All releases of information dated, authorized, and expiration noted
• 42 CFR Part 2 language included on any SUD disclosure
• Court compliance reports kept separate from clinical notes
• Prescriber communications documented with date, content, and outcome
• All outreach attempts logged with date, time, method, and result

Privacy

• 42 CFR Part 2 applicability confirmed for your program
• Re-disclosure prohibition language included in any authorized disclosure
• Expired releases flagged and not acted upon

SUD treatment is demanding clinical work, and the documentation burden that comes with it is real. Getting the documentation right protects your clients, protects you, and creates a clinical record that actually serves the treatment.